Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Thoracic 3Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Lung Neoplasms 1

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Thoracotomy × Thoracic × Clear all
NCT02502318 2024-01-12

LungSco01

Centre Hospitalier Universitaire Dijon

Phase NA Terminated
261 enrolled
Thoracic

Lung Neoplasms

NCT03786003 2023-07-21

ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)

Fudan University

Phase NA Recruiting
1,086 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02360761 2016-09-20

STEPS

Peking University People's Hospital

Phase 3 Unknown
339 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡